Authors:
Velders, MP
Weijzen, S
Eiben, GL
Elmishad, AG
Kloetzel, PM
Higgins, T
Ciccarelli, RB
Evans, M
Man, S
Smith, L
Kast, WM
Citation: Mp. Velders et al., Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine, J IMMUNOL, 166(9), 2001, pp. 5366-5373
Authors:
Boyer, JD
Cohen, AD
Vogt, S
Schumann, K
Nath, B
Ahn, L
Lacy, K
Bagarazzi, ML
Higgins, TJ
Baine, Y
Ciccarelli, RB
Ginsberg, RS
MacGregor, RR
Weiner, DB
Citation: Jd. Boyer et al., Vaccination of seronegative volunteers with a human immunodeficiency virustype 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines, J INFEC DIS, 181(2), 2000, pp. 476-483
Citation: Rr. Macgregor et al., Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env/rev vaccine in HIV-infected recipients: Follow-up data, J INFEC DIS, 181(1), 2000, pp. 406-406
Authors:
Pachuk, CJ
Ciccarelli, RB
Samuel, M
Bayer, ME
Troutman, RD
Zurawski, DV
Schauer, JI
Higgins, TJ
Weiner, DB
Sosnoski, DM
Zurawski, VR
Satishchandran, C
Citation: Cj. Pachuk et al., Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine, BBA-BIOMEMB, 1468(1-2), 2000, pp. 20-30
Authors:
Boyer, JD
Chattergoon, MA
Ugen, KE
Shah, A
Bennett, M
Cohen, A
Nyland, S
Lacy, KE
Bagarazzi, ML
Higgins, TJ
Baine, Y
Ciccarelli, RB
Ginsberg, RS
MacGregor, RR
Weiner, DB
Citation: Jd. Boyer et al., Enhancement of cellular immune response in HIV-1 seropositive individuals:A DNA-based trial, CLIN IMMUNO, 90(1), 1999, pp. 100-107
Authors:
Sin, JI
Ayyavoo, V
Boyer, J
Kim, J
Ciccarelli, RB
Weiner, DB
Citation: Ji. Sin et al., Protective immune correlates can segregate by vaccine type in a murine herpes model system, INT IMMUNOL, 11(11), 1999, pp. 1763-1773
Authors:
Shroff, KE
Marcucci-Borges, LA
de Bruin, SJ
Winter, LA
Tiberio, L
Pachuk, C
Snyder, LA
Satishchandran, C
Ciccarelli, RB
Higgins, TJ
Citation: Ke. Shroff et al., Induction of HSV-gD2 specific CD4(+) cells in Peyer's patches and mucosal antibody responses in mice following DNA immunization by both parenteral and mucosal administration, VACCINE, 18(3-4), 1999, pp. 222-230
Authors:
Sin, JI
Kim, JJ
Boyer, JD
Ciccarelli, RB
Higgins, TJ
Weiner, DB
Citation: Ji. Sin et al., In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model, J VIROLOGY, 73(1), 1999, pp. 501-509
Authors:
Bagarazzi, ML
Boyer, JD
Javadian, MA
Chattergoon, MA
Shah, AR
Cohen, AD
Bennett, MK
Ciccarelli, RB
Ugen, KE
Weiner, DB
Citation: Ml. Bagarazzi et al., Systemic and mucosal immunity is elicited after both intramuscular and intravaginal delivery of human immunodeficiency virus type 1 DNA plasmid vaccines to pregnant chimpanzees, J INFEC DIS, 180(4), 1999, pp. 1351-1355
Authors:
Sin, JI
Kim, JJ
Arnold, RL
Shroff, KE
McCallus, D
Pachuk, C
McElhiney, SP
Wolf, MW
Pompa-de Bruin, SJ
Higgins, TJ
Ciccarelli, RB
Weiner, DB
Citation: Ji. Sin et al., IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4(+) T cell-mediated protective immunity against herpes simplex virus-2 challenge. (vol 162, pg 2912, 1999), J IMMUNOL, 163(2), 1999, pp. 1094-1094
Authors:
Sin, JI
Kim, JJ
Arnold, RL
Shroff, KE
McCallus, D
Pachuk, C
McElhiney, SP
Wolf, MW
Pompa-de Bruin, SJ
Higgins, TJ
Ciccarelli, RB
Weiner, DB
Citation: Ji. Sin et al., IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4(+) T cell-mediated protective immunity against herpes simplex virus-2 challenge, J IMMUNOL, 162(5), 1999, pp. 2912-2921